Breast Cancer Research Review, Issue 15

In this Issue:

Offer BRCA testing for women with HR-low+ tumours
Letrozole favoured over tamoxifen in lobular carcinoma
Neoadjuvant anastrozole vs fulvestrant in HR+ disease
Maintenance olaparib: no long-term safety issues
Time to initiation of adjuvant chemotherapy in early disease
Predictors of occult nipple-areola complex involvement
Predicting benefit of adjuvant docetaxel in ER+ disease
Pregnancy using ART in women with history of breast cancer
Creating an accurate and standardised Ki-67 scoring approach
A novel radiosensitivity signature may predict locoregional recurrence

Please login below to download this issue (PDF)

Subscribe